drugset
drugset / Trial / NCT02599311

the Indications and Clinical Efficacy of Pelvic Organ Prolapse Surgery

NCT02599311 ↗

Phase 3 Unknown 1000 enrolled Peking University People's Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

One thousand patients with stage\>2 POP are recruited. The patients are all received surgeries,such as transvaginal synthetic mesh surgery, the sacral fixation, tissue repair surgery and colpocleisis. The patients with POP who have not undergone surgery are excluded. Postoperatively, the investigators investigate the indications and clinical efficacy of pelvic organ prolapse surgery.

Timeline

Start
2015-08
Primary completion
2019-10
Completion
2020-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolterodine Small molecule — —

Indications

pelvic organ prolapse